Longitudinal Assessment of Amyloid Pathology in Transgenic ArcAβ Mice Using Multi-Parametric Magnetic Resonance Imaging

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Klohs, Jan ^a   Politano, Igna Wojtyna ^a   Deistung, Andreas ^b   Grandjean, Joanes ^a   Drewek, Anna ^c   Dominietto, Marco ^a   Keist, Ruth ^a   Schweser, Ferdinand ^b   Reichenbach, Jürgen R ^b   Nitsch, Roger M ^a   Knuesel, Irene ^a   Rudin, Markus ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^c ETH ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN;

AGE; AMYLOIDOSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APPARENT DIFFUSION COEFFICIENT; ARTICLE; BLOOD BRAIN BARRIER; BRAIN HEMORRHAGE; CEREBRAL AMYLOIDOSIS; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIFFUSION ANISOTROPY; DIFFUSION WEIGHTED IMAGING; DYNAMIC CONTRAST ENHANCEMENT MAGNETIC RESONANCE IMAGING; FEMALE; GENOTYPE; LONGITUDINAL STUDY; MALE; MOUSE; NEUROIMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; QUANTITATIVE SUSCEPTIBILITY MAPPING; RADIOLOGICAL PARAMETERS; SUSCEPTIBILITY WEIGHTED IMAGING; T1 MAPPING; TRANSGENIC MOUSE; ANIMAL; BRAIN; DIAGNOSTIC IMAGING; DISEASE MODEL; GENETICS; PROCEDURES; STATISTICAL MODEL; VASCULAR AMYLOIDOSIS; VASCULARIZATION;

MUS;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN; CEREBRAL AMYLOID ANGIOPATHY; DIFFUSION MAGNETIC RESONANCE IMAGING; DISEASE MODELS, ANIMAL; LINEAR MODELS; LONGITUDINAL STUDIES; MALE; MICE; MICE, TRANSGENIC;

EID: 84879233445     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0066097     Document Type: Article

References (52)

1. Hardy J, Selkoe DJ, (2002) The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297: 353-356.
2. Iadecola C, (2004) Neurovascular regulation in the normal brain and in Alzheimer's disease. Nat Rev Neurosci 5: 347-360.
3. Weller RO, Boche D, Nicoll JA, (2009) Microvasculatur changes and cerebral amyloid angiopathy in Alzheimer's disease and their potential impact on therapy. Acta Neuropathol 118: 87-102.
4. Götz J, Ittner LM, (2008) Animal models of Alzheimer's disease and frontotemporal dementia. Nat Rev Neurosci 9: 532-544.
5. Kahle PJ, Haas C, (2001) The emerging utility of animal models of chronic neurodegenerative diseases. Expert Opin Ther Targets 5: 125-132.
6. Merlini M, Meyer EP, Ulmann-Schuler A, Nitsch RM, (2011) Vascular β-amyloid and early astroctye alterations impair cerebrovascular function and cerebral metabolism in transgenic arcAβ mice. Acta Neuropathol 122: 293-311.
7. Klohs J, Rudin M, (2011) Unveiling molecular events in the brain by noninvasive imaging. Neuroscientist 17: 539-559.
8. Vanhoutte G, Campo A, Van der Linden A, (2011) Validation of dementia models employing neuroimaging techniques. In: Animal models of dementia (2011) PP De Deyn & D Van Dam. Neuromethods, vol. 48, Springer Science+Business Media, LLC. pp. 187-222.
9. Delatour B, Guegan M, Volk A, Dhenain M, (2006) In vivo MRI and histological evaluation of brain atrophy in APP/PS1 transgenic mice. Neurobiol Aging 28: 835-847.
10. Badea A, Johnson GA, Jankowsky JL, (2010) Remote sites of structural atrophy predict later amyloid formation in a mouse model of Alzheimer's disease. Neuroimage 50: 416-427.
11. Song SK, Kim JH, Lin SJ, Brendza RP, Holtzman DM, (2004) Diffusion tensor imaging detects age-dependent white matter changes in a transgenic mouse model with amyloid deposition. Neurobiol Dis 15: 640-647.
12. Mueggler T, Meyer-Lehmann M, Rausch M, Staufenbiehl M, Jucker M, et al. (2004) Restricted diffusion in the brain of transgenic mice with cerebral amyloidosis. Eur J Neurosci 20: 811-817.
13. Sykova E, Vorisek I, Antonova T, Mazel T, Meyer-Luehmann M, et al. (2005) Changes in extracellular space size and geometry in APP23 transgenic mice: a model of Alzheimer's disease. Proc Natl Acad Sci U S A 102: 479-484.
14. Thiessen JD, Glazner KA, Nafez S, Schellenberg AE, Buist R, et al. (2010) Histochemical visualization and diffusion MRI at 7 Tesla in the TgCRND8 transgenic model of Alzheimer's disease. Brain Struct Funct 215: 29-36.
15. Helpern JA, Lee SP, Falangola MF, Dyakin VV, Bogart A, et al. (2004) MRI assessment of neuropathology in a transgenic mouse model of Alzheimer's disease. Magn Reson Med 51: 794-798.
16. El Tannir El Tayara N, Delatour B, Le Cudennec C, Guégan M, Volk A, et al. (2006) Age-related evolution of amyloid burden, iron load, and MR relaxation times in a transgenic mouse model of Alzheimer's disease. Neurobiol Dis 22: 199-208.
17. Falangola MF, Dyakin VV, Lee SP, Bogart A, Babb JS, et al. (2007) Quantitative MRI reveals aging-associated T2 changes in mouse models of Alzheimer's disease. NMR Biomed 20: 343-351.
18. Chamberlain R, Reyes D, Curran GL, Marjanska M, Wengenack TM, et al. (2009) Comparison of amyloid plaque contrast generated by T2-weighted, T2*-weighted, and susceptibility-weighted imaging methods in transgenic mouse models of Alzheimer's disease. Magn Reson Med 61: 1158-1164.
19. Weidensteiner C, Metzger F, Bruns A, Bohrmann B, Kuennecke B, et al. (2009) Cortical hypoperfusion in the B6.PS2APP mouse model for Alzheimer's disease: comprehensive phenotyping of vascular and tissular parameters by MRI. Magn Reson Med 62: 35-45.
20. Klohs J, Baltes C, Princz-Kranz F, Ratering D, Nitsch RM, et al. (2012) Contrast-enhanced magnetic resonance microangiography reveals remodeling of the cerebral microvasculature in transgenic arcAβ mice. J Neurosci 32: 1705-1713.
21. Princz-Kranz FL, Mueggler T, Knobloch M, Nitsch RM, Rudin M, (2010) Vascular response to acetazolamide decreases as a function of age in the arcA beta mouse model of cerebral amyloidosis. Neurobiol Dis 40: 284-292.
22. Klohs J, Deistung A, Schweser F, Grandjean J, Dominietto M, et al. (2011) Detection of cerebral microbleeds with quantitative susceptibility mapping in the ArcAbeta mouse model of cerebral amyloidosis. J Cereb Blood Flow and Metab 31: 2282-2292.
23. Teipel SJ, Peters O, Heuser I, Jessen F, Maier W, et al. (2011) Atrophy outcomes in multicentre clinical trials on Alzheimer's disease: effect of different processing and analysis approaches on sample sizes. World J Biol Psychiatry 12(s1): 109-113.
24. Bernal-Rusiel JL, Greve DN, Reuter M, Fischl B, Sabuncu MR, et al. (2012) Statistical analysis of longitudinal neuroimage data with linear mixed effects models. Neuroimage 66C: 249-260.
25. Venables WN, Ripley BD (2002) Modern applied statistics with S. Springer Science+Business Media.
26. Knobloch M, Konietzko U, Krebs DC, Nitsch RM, (2007) Intracellular Abeta and cognitive deficits precede beta-amyloid deposition in transgenic arcAbeta mice. Neurobiol Aging 28: 1297-1306.
27. de Rochefort L, Liu T, Kressler B, Liu J, Spincemaille P, et al. (2010) Quantitative susceptibility map reconstruction from MR phase data using bayesian regularization: validation and application to brain imaging. Magn Reson Med 63: 194-206.
28. Schweser F, Deistung A, Lehr BW, Reichenbach JR, (2011) Quantitative imaging of intrinsic magnetic tissue properties using MRI signal phase: an approach to in vivo brain iron metabolism? Neuroimage 54: 2789-2807.
29. Schweser F, Sommer K, Deistung A, Reichenbach JR, (2012) Quantitative susceptibility mapping for investigating subtle susceptibility variations in the human brain. Neuroimage 62: 2083-2100.
30. Reichenbach JR, Venkatesan R, Schillinger D, Kido DK, Haacke EM, (1997) Small vessels in the human brain: MR-venography with deoxyhemoglobin as an intrinsic contrast agent. Radiology 204: 272-277.
31. Reichenbach JR, Haacke EM, (2001) High resolution BOLD venographic imaging: a window into brain function. NMR Biomed 14: 453-467.
32. Franklin KBJ, Paxinos G (1997) The mouse brain in stereotaxic coordinates. Academic Press, San Diego, CA.
33. Le Bihan D, (1995) Molecular diffusion, tissue microdynamics and microstructure. NMR Biomed 8: 375-386.
34. Brunberg JA, Chenevert TL, McKeever PE, Ross DA, Junck LR, et al. (1995) In vivo MR determination of water diffusion coefficients and diffusion anisotropy: correlation with structural alteration in gliomas of the cerebral hemispheres. AJNR Am J Neuroradiol 16: 361-371.
35. Gouw AA, Seewann A, Vrenken H, van der Flier WM, Rozemuller JM, et al. (2008) Heterogeneity of white matter hyperintensities in Alzheimer's disease: post-mortem quantitative MRI and neuropathology. Brain 131: 3286-3298.
36. Rudin M, McSheehy PM, Allegrini PR, Rausch M, Baumann D, et al. (2005) PTK787/ZK222584, a tyrosine kinase inhibitor of vascular endothelial growth factor receptor, reduces uptake of the contrast agent GdDOTA by murine orthotopic B16/BL6 melanoma tumours and inhibits their growth in vivo. NMR Biomed 18: 308-321.
37. Abdul-Rahman HS, Gdeisat MA, Burton DR, Lalor MJ, Lilley F, et al. (2007) Fast and robust three-dimensional best path phase unwrapping algorithm. Appl Opt 46: 6623-6635.
38. Liu T, Khalidov I, de Rochefort L, Spincemaille P, Liu J, et al. (2011) A novel background field removal method for MRI using projection onto dipole fields (PDF). NMR Biomed 24: 1129-1136.
39. Cheng YC, Neelavalli J, Haacke EM, (2009) Limitations of calculating field distributions and magnetic susceptibilities in MRI using a Fourier based method. Phys Med Biol 54: 1169-1189.
40. Avants BB, Tustison NJ, Song G, Cook PA, Klein A, et al. (2011) A reproducible evaluation of ANTs similarity metric performance in brain image registration. Neuroimage 5: 2033-2044.
41. R Development Core Team (2012) R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. ISBN 3-900051-07-0. Available: http://www.R-project.org/.
42. Lo RY, Jagust WJ, Alzheimer's Disease Neuroimaging Initiative, (2012) Predicting missing biomarker data in a longitudinal study of Alzheimer disease. Neurology 78: 1376-1382.
43. Van Dam D, De Deyn PP, (2011) Species, Strain, and Gender Issues in the Development and Validation of Animal Models of Dementia. In: Animal Models of Dementia. (2011) Peter Paul De Deyn and Debby Van Dam, Neuromethods, vol. 48, Springer Science+Business Media, LLC. pp. 53-75.
44. Spring S, Lerch JP, Henkelman RM, (2007) Sexual dimorphism revealed in the structure of the mouse brain using three-dimensional magnetic resonance imaging. Neuroimage 35: 1424-1433.
45. Massie HR, Aiello VR, Iodice AA, (1979) Changes with age in copper and superoxide dismutase levels in brains of C57BL/6j mice. Mech Ageing Dev 10: 93-99.
46. O'Callaghan JP, Miller DB, (1991) The concentration of glial fibrillary acidic protein increases with age in the mouse and rat brain. Neurobiol Aging 12: 171-174.
47. Vorbrodt AW, Dobrogowska DH, (1994) Immunocytochemical evaluation of blood-brain barrier to endogenous albumin in adult, newborn and aged mice. Folia Histochem Cytobiol 32: 63-70.
48. Rudick RA, Buell SJ, (1983) Integrity of blood-brain barrier to peroxidase in senescent mice. Neurobiol Aging 4: 283-287.
49. Giesel FL, Mehndiratta A, Essig M, (2010) High-relaxivity contrast-enhanced magnetic resonance neuroimaging: a review. Eur Radiol 20: 2461-2474.
50. Winkler DT, Bondolfi L, Herzig MC, Jann L, Calhoun ME, et al. (2001) Spontaneous hemorrhagic stroke in a mouse model of cerebral amyloid angiopathy. J Neurosci 21: 1619-1627.
51. Thakker DR, Weatherspoon MR, Harrison J, Keene TE, Lane DS, et al. (2009) Intracerebroventricular amyloid-beta antibodies reduce cerebral amyloid angiopathy and associated micro-hemorrhages in aged Tg2576 mice. Proc Natl Acad Sci U S A 106: 4501-4506.
52. Liu C, Li W, Johnson GA, Wu B, (2011) High-field (9.4 T) MRI of brain dymyelination by quantitative mapping of magnetic susceptibility. Neuroimage 56: 930-938.